相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Type II NKT Cells and Their Emerging Role in Health and Disease
Madhav V. Dhodapkar et al.
JOURNAL OF IMMUNOLOGY (2017)
Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma
Laura Escriba-Garcia et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential
Christian W. Keller et al.
FRONTIERS IN IMMUNOLOGY (2017)
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
Mark A. Exley et al.
CLINICAL CANCER RESEARCH (2017)
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis
Francesca Gorini et al.
BLOOD (2017)
Co-operation of α-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model
Tiangeng Dong et al.
BIOCHEMICAL JOURNAL (2016)
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
Yusuf Dolen et al.
ONCOIMMUNOLOGY (2016)
Hallmarks of Tissue-Resident Lymphocytes
Xiying Fan et al.
CELL (2016)
Non-glycosidic compounds can stimulate both human and mouse iNKT cells
John-Paul Jukes et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Immunotherapeutic strategies targeting natural killer T cell responses in cancer
Susannah C. Shissler et al.
IMMUNOGENETICS (2016)
Activation strategies for invariant natural killer T cells
Ayano C. Kohlgruber et al.
IMMUNOGENETICS (2016)
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
Gengwen Tian et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells
Kyle K. Payne et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficient Regeneration of Human Vα24+ Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
Daisuke Yamada et al.
STEM CELLS (2016)
Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells
Shuichi Kitayama et al.
STEM CELL REPORTS (2016)
CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
Linnea Veinotte et al.
ONCOIMMUNOLOGY (2016)
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents
Leandro J. Carreno et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional
Wenji Sun et al.
CYTOKINE (2015)
Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response
You Jeong Lee et al.
IMMUNITY (2015)
The burgeoning family of unconventional T cells
Dale I. Godfrey et al.
NATURE IMMUNOLOGY (2015)
A new mouse strain for the analysis of invariant NKT cell function
Shilpi Chandra et al.
NATURE IMMUNOLOGY (2015)
Synthesis and Activity of 6-Deoxy-6-thio-α-GalCer and Peptide Conjugates
Benjamin J. Compton et al.
ORGANIC LETTERS (2015)
The Regulatory Role of Invariant NKT Cells in Tumor Immunity
Rosanna M. McEwen-Smith et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Antitumor Responses of Invariant Natural Killer T Cells
Jennie B. Altman et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
The role of invariant natural killer T cells in dendritic cell licensing, cross-priming, and memory CD8+ T cell generation
Catherine Gottschalk et al.
FRONTIERS IN IMMUNOLOGY (2015)
The extended family of CD1d-restricted NKT cells: sifting through a mixed bag of TCRs, antigens, and functions
Elodie Macho-Fernandez et al.
FRONTIERS IN IMMUNOLOGY (2015)
Type II nKT cells in inflammation, autoimmunity, microbial immunity, and cancer
Idania Marrero et al.
FRONTIERS IN IMMUNOLOGY (2015)
Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
Shiny Nair et al.
BLOOD (2015)
CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
Tsung Wen Chong et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Biology of CD1-and MR1-Restricted T Cells
Mariolina Salio et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment
John D. Gibbins et al.
BLOOD (2014)
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey et al.
BLOOD (2014)
Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
Haneen Nur et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Optimization of Natural Killer T Cell-Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector Vaccines
C. Faveeuw et al.
CANCER RESEARCH (2014)
iNKT Cells: Innate Lymphocytes with a Diverse Response
Marta Monteiro et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2014)
iNKT-cell help to B cells: A cooperative job between innate and adaptive immune responses
Paolo Dellabona et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis
Ivan J. Fuss et al.
GUT (2014)
Optimizing NKT cell ligands as vaccine adjuvants
Leandro J. Carreno et al.
IMMUNOTHERAPY (2014)
IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset
Duygu Sag et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Role and Regulation of CD1d in Normal and Pathological B Cells
Mohammed S. Chaudhry et al.
JOURNAL OF IMMUNOLOGY (2014)
Targeted Delivery of α-Galactosylceramide to CD8α+ Dendritic Cells Optimizes Type I NKT Cell-Based Antitumor Responses
Elodie Macho-Fernandez et al.
JOURNAL OF IMMUNOLOGY (2014)
CD1d expression as a prognostic marker for chronic lymphocytic leukemia
Athanasios Anastasiadis et al.
LEUKEMIA & LYMPHOMA (2014)
CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis
Agnieszka Bojarska-Junak et al.
LEUKEMIA RESEARCH (2014)
Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response
Jie Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
iNKT Cell Cytotoxic Responses Control T-Lymphoma Growth In Vitro and In Vivo
Hamid Bassiri et al.
CANCER IMMUNOLOGY RESEARCH (2014)
NKT cell networks in the regulation of tumor immunity
Faith C. Robertson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
Jie Zhao et al.
ONCOIMMUNOLOGY (2014)
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
Joshua Richter et al.
BLOOD (2013)
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
Stephanie Corgnac et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
Daofeng Liu et al.
CLINICAL IMMUNOLOGY (2013)
Transcriptional regulation of the NKT cell lineage
Michael G. Constantinides et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma
Sungyoul Hong et al.
IMMUNOLOGY LETTERS (2013)
Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex
Takashi Nakamura et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells
Nadia R. Cohen et al.
NATURE IMMUNOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs
Raju V. V. Tatituri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity
Aleksandra M. Dudek et al.
FRONTIERS IN IMMUNOLOGY (2013)
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
Patrick J. Brennan et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Primary immunodeficiency associated with defects in CD1 and CD1-restricted T cells
Sebastian Zeissig et al.
YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY III (2012)
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
Stephen R. Mattarollo et al.
BLOOD (2012)
Invariant NKT cells increase drug-induced osteosarcoma cell death
S. Fallarini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
Karsten A. Pilones et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy
L. G. Durrant et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells
Enrico Girardi et al.
IMMUNOLOGICAL REVIEWS (2012)
Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia
Alicia E. Najera Chuc et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Accumulation of Activated Invariant Natural Killer T Cells in the Tumor Microenvironment after α-Galactosylceramide-Pulsed Antigen Presenting Cells
Kaoru Nagato et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up
Famke L. Schneiders et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1-Dependent Regulation of Type 1 Diabetes
Nadir Kadri et al.
JOURNAL OF IMMUNOLOGY (2012)
Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor
Onisha Patel et al.
NATURE IMMUNOLOGY (2012)
Lower TCR repertoire diversity in Traj18-deficient mice
Romain Bedel et al.
NATURE IMMUNOLOGY (2012)
Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens
Enrico Girardi et al.
NATURE IMMUNOLOGY (2012)
iNKT Cells Suppress the CD8+ T Cell Response to a Murine Burkitt's-Like B Cell Lymphoma
Ryan L. Bjordahl et al.
PLOS ONE (2012)
Immunomodulatory Type II Natural Killer T Lymphocytes in Health and Disease
S. Rhost et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells
Hak-Jong Choi et al.
BLOOD (2011)
Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
Andrew J. Nicol et al.
CLINICAL CANCER RESEARCH (2011)
Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer
Shinichiro Motohashi et al.
CLINICAL IMMUNOLOGY (2011)
Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
Kazuki Yamasaki et al.
CLINICAL IMMUNOLOGY (2011)
Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
Leonid S. Metelitsa
CLINICAL IMMUNOLOGY (2011)
Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: Reversing tumor-induced defects
Mark A. Exley et al.
CLINICAL IMMUNOLOGY (2011)
Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection
Manfred Brigl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Sulfatide-Reactive Natural Killer T Cells Abrogate Ischemia-Reperfusion Injury
Seung Hee Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
Laura M. Hix et al.
PLOS ONE (2011)
NKT Cell Exacerbation of Liver Metastases Arising from Melanomas Transplanted into Either the Eyes or Spleens of Mice
Wanhua Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Transcriptional control of invariant NKT cell development
Rupali Das et al.
IMMUNOLOGICAL REVIEWS (2010)
Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand
Troels R. Petersen et al.
IMMUNOLOGY AND CELL BIOLOGY (2010)
Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells
Hiroshi Watarai et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V alpha 14i NKT Cells
Barbara A. Sullivan et al.
JOURNAL OF IMMUNOLOGY (2010)
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
Gerhard Wingender et al.
JOURNAL OF IMMUNOLOGY (2010)
CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV
Shiho Miura et al.
JOURNAL OF VIROLOGY (2010)
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
Verena Semmling et al.
NATURE IMMUNOLOGY (2010)
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
Carmela De Santo et al.
NATURE IMMUNOLOGY (2010)
The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage
Taishan Hu et al.
NATURE IMMUNOLOGY (2010)
Defective NKT Cell Activation by CD1d+TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
Michael Nowak et al.
PLOS ONE (2010)
Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a β-linked self-glycolipid
Philomena Arrenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Antigen recognition by CD1d-restricted NKT T cell receptors
Dale I. Godfrey et al.
SEMINARS IN IMMUNOLOGY (2010)
Lipid and glycolipid antigens of CD1d-restricted natural killer T cells
Manjunatha M. Venkataswamy et al.
SEMINARS IN IMMUNOLOGY (2010)
DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
Daejin Kim et al.
VACCINE (2010)
Regulation of multiple myeloma survival and progression by CD1d
Emmanouil Spanoudakis et al.
BLOOD (2009)
Combination therapy of in vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
Naoki Kunii et al.
CANCER SCIENCE (2009)
Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade
Karsten A. Pilones et al.
CLINICAL CANCER RESEARCH (2009)
Natural Killer T Cells and Autoimmune Disease
Lan Wu et al.
CURRENT MOLECULAR MEDICINE (2009)
The Contrasting Roles of NKT Cells in Tumor Immunity
Jay A. Berzofsky et al.
CURRENT MOLECULAR MEDICINE (2009)
Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells
Maria Blomqvist et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The presence of CD8+ invariant NKT cells in mice
Hyunji Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms
Davide Bagnara et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Differential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell Receptors
Daniel G. Pellicci et al.
IMMUNITY (2009)
Cross-Regulation Between Distinct Natural Killer T Cell Subsets Influences Immune Response to Self and Foreign Antigens
Philomena Arrenberg et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
V alpha 24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Liping Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
CD1d Activation and Blockade: A New Antitumor Strategy
Michele W. L. Teng et al.
JOURNAL OF IMMUNOLOGY (2009)
CD1d-Based Combination Therapy Eradicates Established Tumors in Mice
Michele W. L. Teng et al.
JOURNAL OF IMMUNOLOGY (2009)
Selective Requirement for c-Myc at an Early Stage of Vα14i NKT Cell Development
Marcin P. Mycko et al.
JOURNAL OF IMMUNOLOGY (2009)
Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
Hyun-Jeong Ko et al.
JOURNAL OF IMMUNOLOGY (2009)
PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
Vrajesh V. Parekh et al.
JOURNAL OF IMMUNOLOGY (2009)
A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
Shinichiro Motohashi et al.
JOURNAL OF IMMUNOLOGY (2009)
Intrathymic proliferation wave essential for Vα14+ natural killer T cell development depends on c-Myc
Marei Dose et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
David H. Chang et al.
BLOOD (2008)
CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system
Jennifer L. Matsuda et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: Implications for posttransplant survival
Angela Shaulov et al.
EXPERIMENTAL HEMATOLOGY (2008)
The transcription factor PLZF directs the effector program of the NKT cell lineage
Adam K. Savage et al.
IMMUNITY (2008)
α-Galactosylceramide-loaded, antigen-expressing B cells prime a wide spectrum of antitumor immunity
Yeon-Jeong Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induced antitumor effects in mice
Kathrin Stirnemann et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans
Carmela De Santo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type IINKT cells
Keshab Chandra Roy et al.
JOURNAL OF IMMUNOLOGY (2008)
Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells
Vadim Y. Taraban et al.
JOURNAL OF IMMUNOLOGY (2008)
NKT cells in tumor immunity: Opposing subsets define a new immunoregulatory axis
Jay A. Berzofsky et al.
JOURNAL OF IMMUNOLOGY (2008)
Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells
Elitza Germanov et al.
JOURNAL OF IMMUNOLOGY (2008)
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions
Damian Kovalovsky et al.
NATURE IMMUNOLOGY (2008)
Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation
Marie-Laure Michel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
Jonathan M. Coquet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
NK T cells provide lipid antigen-specific cognate help for B cells
Elizabeth A. Leadbetter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo
Patricia Barral et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer
Tetsuro Uchida et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells
Takeshi Shimaoka et al.
JOURNAL OF IMMUNOLOGY (2007)
Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity
Shin-Ichiro Fujii et al.
IMMUNOLOGICAL REVIEWS (2007)
Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis
Elena Ambrosino et al.
JOURNAL OF IMMUNOLOGY (2007)
An NKT mediated autologous vaccine generates CD4 T-cell-dependent potent antilymphoma immunity
Yeonseok Chung et al.
BLOOD (2007)
Type IINKT cell-mediated anergy induction in type INKT cells prevents inflammatory liver disease
Ramesh C. Halder et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma
Johan W. Molling et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumor cells loaded with α-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice
Kanako Shimizu et al.
JOURNAL OF IMMUNOLOGY (2007)
GATA-3 regulates the development and function of invariant NKT cells
Peter J. Kim et al.
JOURNAL OF IMMUNOLOGY (2006)
A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer
Shinichiro Motohashi et al.
CLINICAL CANCER RESEARCH (2006)
CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells
Kyoko Haraguchi et al.
LEUKEMIA & LYMPHOMA (2006)
Evaluation of the function of human invariant NKT cells from cancer patients using α-galactosylceramide-loaded murine dendritic cells
Kanako Shimizu et al.
JOURNAL OF IMMUNOLOGY (2006)
Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
S. Nagaraj et al.
INTERNATIONAL IMMUNOLOGY (2006)
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
Shin-ichiro Fujii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo
Yeonseok Chung et al.
CANCER RESEARCH (2006)
Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo
Gourapura J. Renukaradhya et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
T-bet concomitantly controls migration, survival, and effector functions during the development of Vα14i NKT cells
JL Matsuda et al.
BLOOD (2006)
A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
K Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Therapeutic effect of α-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells
H Matsuyoshi et al.
CANCER SCIENCE (2005)
Differential antitumor immunity mediated by NKT cell subsets in vivo
NY Crowe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Increased intratumor Vα24-positive natural killer T cells:: A prognostic factor for primary colorectal carcinomas
T Tachibana et al.
CLINICAL CANCER RESEARCH (2005)
Glycolipid antigen induces long-term natural killer T cell anergy in mice
VV Parekh et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Peripheral blood IFN-γ-secreting Vα24+Vβ11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load
JW Molling et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Dendritic cell maturation by innate lymphocytes:: coordinated stimulation of innate and adaptive immunity
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors
T Egawa et al.
IMMUNITY (2005)
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
DH Chang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product
B Pasquier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Regulation of NKT cell development by SAP, the protein defective in XLP
KE Nichols et al.
NATURE MEDICINE (2005)
A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer
A Ishikawa et al.
CLINICAL CANCER RESEARCH (2005)
The peripheral blood Vα24+NKT cell numbers decrease in patients with haematopoietic malignancy
K Yoneda et al.
LEUKEMIA RESEARCH (2005)
Dendritic cell-mediated T cell polarization
EC de Jong et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells
MJ Townsend et al.
IMMUNITY (2004)
Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity
M Nieda et al.
BLOOD (2004)
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy
JD Silk et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The immunoregulatory role of CD1d-restricted natural killer T cells in disease
HJJ van der Vliet et al.
CLINICAL IMMUNOLOGY (2004)
alpha-Galactosylceramide: Potential immunomodulatory activity and future application
Y Hayakawa et al.
CURRENT MEDICINAL CHEMISTRY (2004)
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Parallels and distinctions between T and NKT cell development in the thymus
SP Berzins et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion
KM Dhodapkar et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2
LS Metelitsa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells
IF Hermans et al.
JOURNAL OF IMMUNOLOGY (2003)
Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function
DB Stetson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
α-galactosylceramide (KRN7000) suppression of chernical- and oncogene-dependent carcinogenesis
Y Hayakawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Severe and selective deficiency of interferon-γ-producing invariant natural killer T cells in patients with myelodysplastic syndromes
S Fujii et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
S Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CD1d-restricted help to B cells by human invariant natural killer T lymphocytes
G Galli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CD1-dependent dendritic cell instruction
MS Vincent et al.
NATURE IMMUNOLOGY (2002)
Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs
S Fujii et al.
NATURE IMMUNOLOGY (2002)
The unconventional lifestyle of NKT cells
M Kronenberg et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Impaired proliferative response of Vα24 NKT cells from cancer patients against α-galactosylceramide
K Yanagisawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells
V Sriram et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Vα24-JαQ-independent, CD1d-restricted recognition of α-galactosylceramide by human CD4+ and CD8αβ+ T lymphocytes
SD Gadola et al.
JOURNAL OF IMMUNOLOGY (2002)
NKT cells - conductors of tumor immunity?
MJ Smyth et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining
JE Gumperz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Distinct functional lineages of human Vα-24 natural killer T cells
PT Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Human umbilical cord blood NK T cells kill tumors by multiple cytotoxic mechanisms
B Gansuvd et al.
HUMAN IMMUNOLOGY (2002)
Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells
M Hagihara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis
AW Jahng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Cutting edge: A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses
MA Exley et al.
JOURNAL OF IMMUNOLOGY (2001)
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
M Terabe et al.
NATURE IMMUNOLOGY (2000)
Immune suppression and skin cancer development: regulation by NKT cells
AM Moodycliffe et al.
NATURE IMMUNOLOGY (2000)
NKT cells: facts, functions and fallacies
DI Godfrey et al.
IMMUNOLOGY TODAY (2000)
The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
T Nishimura et al.
INTERNATIONAL IMMUNOLOGY (2000)
Human invariant Vα24+ natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells
A Nicol et al.
IMMUNOLOGY (2000)
Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells
R Nakagawa et al.
ONCOLOGY RESEARCH (2000)
Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells1
M Nakui et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
分享论文
